Obesity and smoking in patients with schizophrenia and normal controls: A case-control study

Psychiatry Research

Volumn 176, Issue 1, 2010, Pages 13-16

  Fountoulakis, Konstantinos N ^a   Siamouli, Melina ^b   Panagiotidis, Panagiotis ^c   Magiria, Stamatia ^a   Kantartzis, Sotiris ^b   Papastergiou, Natalia ^a   Shoretsanitis, George ^a   Pantoula, Eleonora ^b   Moutou, Katerina ^b   Kouidi, Evangelia ^a   Deres, Symeon ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Asklepeios Mental Hospital   (Greece)

^c 424 General Army Hospital   (Greece)

Author keywords

Body fat; Metabolic syndrome; Obesity; Schizophrenia

Indexed keywords

ADULT; AGED; ARTICLE; BODY FAT; BODY HEIGHT; BODY MASS; BODY SURFACE; BODY WEIGHT; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE DURATION; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBESITY; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; PRIVATE HOSPITAL; SCHIZOPHRENIA; SEX DIFFERENCE; SMOKING HABIT; WAIST CIRCUMFERENCE;

ADIPOSE TISSUE; ADULT; AGED; ANALYSIS OF VARIANCE; ANTHROPOMETRY; BODY MASS INDEX; BODY SURFACE AREA; BODY WEIGHT; CASE-CONTROL STUDIES; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; OBESITY; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SCHIZOPHRENIA; SEX FACTORS; SMOKING; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 76549083163     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2008.11.018     Document Type: Article

References (20)

1. Allison D.B., Fontaine K.R., Heo M., Mentore J.L., Cappelleri J.C., Chandler L.P., Weiden P.J., and Cheskin L.J. The distribution of body mass index among individuals with and without schizophrenia. Journal of Clinical Psychiatry 60 (1999) 215-220
2. Bobes J., Arango C., Aranda P., Carmena R., Garcia-Garcia M., and Rejas J. Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study. Schizophrenia Research 90 (2007) 162-173
3. Bobes J., Rejas J., Garcia-Garcia M., Rico-Villademoros F., Garcia-Portilla M.P., Fernandez I., and Hernandez G. Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study. Schizophrenia Research 62 (2003) 77-88
4. Cohn T., Prud'homme D., Streiner D., Kameh H., and Remington G. Characterizing coronary heart disease risk in chronic schizophrenia: high prevalecne of the metabolic syndrome. Canadian Journal of Psychiatry 49 (2004) 753-760
5. Cohn T.A., and Remington G. Risk factors for coronary heart disease in longterm patients on antipsychotic drugs: high prevalence of syndrome X. Schizophrenia Research 60 (2003) 353-354
6. Coodin S. Body mass index in persons with schizophrenia. Canadian Journal of Psychiatry 46 (2001) 549-555
7. Gilmore J. Body mass index and health. Health Reports 11 (1999) 31-43
8. Hagg S., Lindblom Y., Mjorndal T., and Adolfsson R. High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia. International Clinical Psychopharmacology 21 (2006) 93-98
9. Heiskanen T., Niskanen L., Lyytikainen R., Saarinrn P.I., and Hintikka J. Metabolic syndrome in patients with schizophrenia. Journal of Clinical Psychiatry 64 (2003) 575-579
10. Henderson D.C., Borba C.P., Daley T.B., Boxill R., Nguyen D.D., Culhane M.A., Louie P., Cather C., Eden Evins A., Freudenreich O., Taber S.M., and Goff D.C. Dietary intake profile of patients with schizophrenia. Annals of Clinical Psychiatry 18 (2006) 99-105
11. Homel P., Casey D., and Allison D.B. Changes in body mass index for individuals with and without schizophrenia, 1987-1996. Schizophrenia Research 55 (2002) 277-284
12. Japanese Ministry of Health Labour and Welfare. Health and Nutrition Survey in 2003 (2003)
13. Kitabayashi Y., Narumoto J., Kitabayashi M., and Fukui K. Body mass index among Japanese inpatients with schizophrenia. International Journal of Psychiatry in Medicine 36 (2006) 93-102
14. McEvoy J.P., Meyer J.M., Goff D.C., Nasrallah H.A., Davis S.M., Sullivan L., Meltzer H.Y., Hsiao J., Scott Stroup T., and Lieberman J.A. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research 80 (2005) 19-32
15. Meyer J.M., Nasrallah H.A., McEvoy J.P., Goff D.C., Davis S.M., Chakos M., Patel J.K., Keefe S.E., Stroup T.S., and Lieberman J.A. The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial: clinical comparison of subgroups with and without the metabolic syndrome. Schizophrenia Research 80 (2005) 9-18
16. Saari K., Lindeman S., Viilo K., Isohanni M., Jarvelin M.R., Lauren L., Savolainen M., and Koponen H. A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 birth cohort study. Journal of Clinical Psychiatry 66 (2005) 559-563
17. Susce M.T., Villanueva N., Diaz F.J., and de Leon J. Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey. Journal of Clinical Psychiatry 66 (2005) 167-173
18. Thakore J.H., Mann J.N., Vlahos I., Martin A., and Reznek R. Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. International Journal of Obesity Related Metabolic Disorders 26 (2002) 137-141
19. Weiser M., Knobler H., Lubin G., Nahon D., Kravitz E., Caspi A., Noy S., Knobler H.Y., and Davidson M. Body mass index and future schizophrenia in Israeli male adolescents. Journal of Clinical Psychiatry 65 (2004) 1546-1549
20. Wing J., Babor T., and Brugha T. SCAN: Schedules for Clinical Assessment in Neuropsychiatry. Archives of General Psychiatry 47 (1990) 589-593